Pricing Log in Create free account

Candel Therapeutics, Inc. (CADL) vs Sagimet Biosciences Inc. (SGMT)

Candel Therapeutics, Inc. and Sagimet Biosciences Inc. are both Biotechnology companies. Candel Therapeutics, Inc. and Sagimet Biosciences Inc. are of similar size ($641.5M and $615.2M). Across the 10 metrics below, Sagimet Biosciences Inc. leads on 7 and Candel Therapeutics, Inc. on 3.

Valuation

Metric CADL SGMT Biotechnology median
P/E n/m n/m 10.60
P/S 5,135.81 n/m 9.40
P/B 5.09 2.04 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 3,939.74 n/m 9.02
Earnings yield (16.28%) (13.03%) (32.88%)
Free cash flow yield (8.92%) (8.00%) (23.13%)

Profitability

Metric CADL SGMT Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (81.84%) (24.37%) (51.96%)
Return on assets (56.37%) (23.49%) (46.06%)
Return on invested capital 0.00% (205.24%) 0.00%

Growth

Metric CADL SGMT Biotechnology median
Revenue growth (TTM) 0.00% — 6.76%
EPS growth (last fiscal year) 58.62% (8.97%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CADL SGMT Biotechnology median
Debt to equity 0.38 0.00 0.00
Current ratio 16.09 45.02 4.97
Net debt to EBITDA 1.53 1.98 1.01

Dividend

Metric CADL SGMT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CADL SGMT Biotechnology median
Market cap 615.21m 641.51m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack